FRA
BMY icon

Front Row Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Front Row Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-948
Closed -$39.4K – 546
2024
Q2 		$39.4K Sell
948
-325
-26% -$14.5K 0.01% 299
2024
Q1 		$69K Buy
+1,273
New +$64.8K 0.03% 223
2023
Q4 		– Sell
-1,299
Closed -$75.4K – 517
2023
Q3 		$75.4K Sell
1,299
-2
-0.2% -$123 0.03% 196
2023
Q2 		$83K Buy
1,301
+11
+0.9% +$738 0.04% 189
2023
Q1 		$89K Buy
1,290
+68
+6% +$4.8K 0.04% 182
2022
Q4 		$88K Buy
1,222
+182
+18% +$13.7K 0.05% 187
2022
Q3 		$74K Buy
1,040
+100
+11% +$7.25K 0.04% 199
2022
Q2 		$73K Sell
940
-3
-0.3% -$228 0.04% 206
2022
Q1 		$69K Sell
943
-18
-2% -$1.21K 0.03% 226
2021
Q4 		$60K Buy
961
+50
+5% +$2.93K 0.02% 248
2021
Q3 		$54K Hold
911
– – 0.02% 255
2021
Q2 		$62K Buy
911
+188
+26% +$12.3K 0.03% 247
2021
Q1 		$46K Hold
723
– – 0.02% 271
2020
Q4 		$45K Hold
723
– – 0.02% 270
2020
Q3 		$46K Sell
723
-41
-5% -$2.47K 0.02% 257
2020
Q2 		$45K Hold
764
– – 0.03% 230
2020
Q1 		$47K Buy
764
+41
+6% +$2.51K 0.03% 220
2019
Q4 		$46K Hold
723
– – 0.03% 213
2019
Q3 		$37K Hold
723
– – 0.03% 228
2019
Q2 		$33K Hold
723
– – 0.02% 239
2019
Q1 		$34K Hold
723
– – 0.03% 237
2018
Q4 		$38K Sell
723
-18,930
-96% -$1.02M 0.03% 215
2018
Q3 		$960K Buy
19,653
+765
+4% +$45.4K 0.67% 44
2018
Q2 		$1.11M Sell
18,888
-260
-1% -$14K 0.71% 41
2018
Q1 		$1.21M Buy
19,148
+3,535
+23% +$227K 0.85% 32
2017
Q4 		$957K Buy
+15,613
New +$977K 0.76% 37

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Front Row Advisors's BMY Position: Q3 2024 in Review

Front Row Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 948 shares — an estimated $39.4K sold.

Front Row Advisors first reported a position in BMY in Q4 2017 and held it in 26 quarters. The position peaked at $1.21M in Q1 2018. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Front Row Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 948 Bristol-Myers Squibb shares in Q3 2024, an estimated $39.4K.
  • Front Row Advisors first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Bristol-Myers Squibb position peaked at $1.21M in Q1 2018.
  • 2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.